Ectoparasite saliva proteins and apparatus to collect such proteins
AssigneeHeska Corporation
InventorsGlenn R. Frank, Shirley Wu Hunter, Lynda Wallenfels
Life of this patent
Estimating the term…
Loading patent…
AssigneeHeska Corporation
InventorsGlenn R. Frank, Shirley Wu Hunter, Lynda Wallenfels
Estimating the term…
The present invention is directed to a novel product and method for isolating ectoparasite saliva proteins, and a novel product and method for detecting and/or treating allergic dermatitis in an animal. The present invention includes a saliva protein collection apparatus capable of collecting ectoparasite saliva proteins substantially free of contaminating material. The present invention also relates to ectoparasite saliva proteins, nucleic acid molecules having sequences that encode such proteins, and antibodies raised against such proteins. The present invention also includes methods to obtain such proteins and to use such proteins to identify animals susceptible to or having allergic dermatitis. The present invention also includes therapeutic compositions comprising such proteins and their use to treat animals susceptible to or having allergic dermatitis.
A composition comprising a protein selected from the group consisting of fspE, fspF, fspG, fspH, fspI, fspJ1, fspJ2, fspK, fspL1, fspL2, fspM, fspN1, fspN2, fspN3 and mixtures thereof.
A flea saliva protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:25 and SEQ ID NO:26.
A composition comprising at least one isolated flea saliva protein, wherein said flea saliva protein is included in a protein peak as represented in FIG. 2, said peak being selected from the group consisting of peak E, peak F, peak G, peak H, peak I, peak J, peak K, peak L, peak M and peak N.
A composition comprising at least one isolated flea saliva product substantially free of contaminating material, said composition being produced by a process comprising:
A composition comprising an isolated flea saliva product, wherein said composition, when submitted to high pressure liquid chromatography under conditions equivalent to use of a 15 cm.times.0.46 cm C4 column and a gradient of from about 0.1% trifluoroacetic acid in water to about 0.085% trifluoroacetic acid in 90% acetonitrile, at a flow rate of 0.8 milliliters per minute, comprises a fractionation profile as depicted in FIG. 2.
A composition comprising at least one isolated flea saliva product substantially free of contaminating material, said composition being produced by a process comprising:
A composition comprising at least one isolated flea saliva protein, wherein said flea saliva protein is as isolated from a protein peak as represented in FIG. 2, said peak being selected from the group consisting of peak E, peak F, peak G, peak H, peak I, peak J, peak K, peak L, peak M and peak N, wherein said peak is produced by the method comprising:
A composition comprising a flea saliva extract selected from the group consisting of FS-1 flea saliva extract, FS-2 flea saliva extract, and mixtures thereof.
Dependencies are inferred from the claim text.